Farallon Capital Management LLC Aptinyx Inc. Transaction History

Farallon Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$2.84 - $4.25 $754,281 - $1.13 Million	-265,592 Reduced 39.4%	408,549 $1.4 Million
Q3 2019 Nov 14, 2019	BUY	$3.0 - $4.08 $12,423 - $16,895	4,141 Added 0.62%	674,141 $2.35 Million
Q3 2018 Nov 14, 2018	BUY	$20.21 - $31.85 $1.48 Million - $2.33 Million	73,200 Added 12.27%	670,000 $19.4 Million
Q2 2018 Aug 14, 2018	BUY	$19.83 - $24.17 $11.8 Million - $14.4 Million	596,800 New	596,800 $14.4 Million

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.